Additionally, analyses of hippocampal and cortical recordings of a subset of DS mice 2 weeks after injection demonstrated that CAV-SCN1A injections reduced (P < 0.05) the number of epileptic spikes in both regions (Figure 6, D–G). Here, SCN1A is linked to Dravet syndrome.